Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.58 - $4.68 $2,322 - $4,212
-900 Reduced 3.47%
25,071 $115,000
Q3 2022

Nov 14, 2022

BUY
$2.7 - $4.3 $1,620 - $2,580
600 Added 2.36%
25,971 $216,000
Q2 2022

Aug 12, 2022

SELL
$3.11 - $7.48 $38,875 - $93,500
-12,500 Reduced 33.01%
25,371 $218,000
Q1 2022

May 12, 2022

SELL
$4.88 - $8.56 $52,601 - $92,268
-10,779 Reduced 22.16%
37,871 $174,000
Q4 2021

Feb 14, 2022

SELL
$7.03 - $13.03 $187,701 - $347,901
-26,700 Reduced 35.43%
48,650 $489,000
Q3 2021

Nov 10, 2021

BUY
$11.11 - $17.84 $149,829 - $240,590
13,486 Added 21.8%
75,350 $403,000
Q2 2021

Aug 11, 2021

BUY
$13.68 - $22.34 $846,299 - $1.38 Million
61,864 New
61,864 $350,000
Q1 2021

May 14, 2021

SELL
$9.0 - $63.91 $589,500 - $4.19 Million
-65,500 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$4.82 - $10.1 $315,710 - $661,550
65,500 New
65,500 $282,000
Q3 2020

Nov 13, 2020

SELL
$4.7 - $8.7 $214,320 - $396,719
-45,600 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$5.54 - $10.81 $252,624 - $492,936
45,600 New
45,600 $336,000
Q4 2019

Feb 11, 2020

SELL
$15.72 - $24.88 $929,052 - $1.47 Million
-59,100 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$24.74 - $49.3 $628,396 - $1.25 Million
25,400 Added 75.37%
59,100 $2.2 Million
Q2 2019

Aug 14, 2019

SELL
$34.66 - $63.73 $155,969 - $286,785
-4,500 Reduced 11.78%
33,700 $1.22 Million
Q1 2019

May 10, 2019

SELL
$64.85 - $100.15 $3.24 Million - $5.01 Million
-50,000 Reduced 56.69%
38,200 $4.26 Million
Q4 2018

Feb 12, 2019

SELL
$65.89 - $165.64 $1.98 Million - $4.97 Million
-30,000 Reduced 25.38%
88,200 $19.8 Million
Q3 2018

Nov 09, 2018

BUY
$22.1 - $214.06 $2.61 Million - $25.3 Million
118,200 New
118,200 $12.2 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $874M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.